Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

October 31, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2025

Conditions
Miscarriage
Interventions
BIOLOGICAL

Lymphocyte immunophenotyping

If the patient accepts the ancillary study, a blood sample will be taken (1 EDTA tube of 3 ml and 2 lithium heparin tubes of 10 mL each) for lymphocyte immunophenotyping in flow cytometry on fresh blood and for the constitution of the biological collection (plasma/mononuclear cells).

Trial Locations (1)

75012

Internal medicine department, hospital Saint Antoine, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT05557201 - Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors | Biotech Hunter | Biotech Hunter